Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections

Clin Transplant. 2009 Mar-Apr;23(2):228-32. doi: 10.1111/j.1399-0012.2008.00909.x.

Abstract

Eighteen patients (12 men and 6 women) with aplastic anemia and active fungal infections (10 proven/probable; 8 possible) underwent stem cell transplantation using fludarabine combined with cyclophosphamide or total body irradiation. Peripheral blood stem cells (PBSC) were the main graft source and a combination of cyclosporine with either methotrexate or methylprednisolone was used for graft versus host disease prophylaxis. Fourteen patients (77.8%) achieved neutrophil engraftment after a median time of 11 d, while four died of fungal sepsis. Resolution of fungal infection occurred in 60% of patients with proven/probable infections and in 100% with possible fungal infections. At a median follow up of 30 months, 11 patients (61.1%) were alive and well. Fludarabine-based conditioning regimens with PBSC transplantation can be used successfully in patients with aplastic anemia and fungal infections.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / therapy*
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Female
  • Graft Survival*
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control
  • Graft vs Host Disease / surgery
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Mycoses / microbiology
  • Mycoses / therapy*
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives
  • Whole-Body Irradiation
  • Young Adult

Substances

  • Antifungal Agents
  • Cyclophosphamide
  • Vidarabine
  • fludarabine